A Review of a Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

This publication is sponsored by Insulet Corporation.

This Clinical Brief provides key information regarding the results of a pivotal clinical trial of a tubeless, on-body automated insulin delivery system in pediatric and adult patients with type 1 diabetes. An interview with trial investigators offers insights on the impact of advances in technology on disease management and treatment.

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

A Review of a Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

Trending on AJMC

Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention

INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD

AI Reshaping Diabetes Care From Nutrition to Clinical Decisions

Social Factors Shape Diabetes, Dementia Risk Across Populations

First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD